Literature DB >> 30500390

Updating the evidence relating smoking bans to incidence of heart disease.

Peter N Lee1, John S Fry2, Alison J Thornton3.   

Abstract

In our latest update of the evidence on smoking bans and heart disease we summarize 59 studies. We take account of the underlying trends in incidence rates as far as possible by using control data in eight studies, and by adjustment based on observed trends in cases pre- and post-ban in 40 studies, being unable to make an adjustment in the remaining 11 studies. Overall, based on 62 independent estimates from the 59 studies, we estimate that bans reduce incidence by 5.0% (95% CI 3.2-6.8%), though this estimate reduces to 2.9% (0.01-5.6%) when we exclude regional estimates where national estimates are available, and studies where trend adjustment is not possible. For 25 of the studies, quadratic rather than linear adjustment is possible, but this hardly affects the overall estimates. Ban effects are somewhat greater when the pre-ban period studied is relatively short, and in smaller studies. We compare our findings with those in other recent reviews, one of which totally ignored underlying trends and results from control populations. We discuss reasons why we believe there is likely to be a true small effect of smoking bans, and weaknesses in the data which preclude reaching any very confident conclusion.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cessation; Heart disease; Smoking bans; Tobacco

Mesh:

Year:  2018        PMID: 30500390     DOI: 10.1016/j.yrtph.2018.11.014

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Declining cardiovascular mortality masks unpalatable inequalities.

Authors:  Alastair H Leyland; Ruth Dundas
Journal:  Heart       Date:  2019-10-15       Impact factor: 5.994

2.  Extension of Public Smoking Ban Was Not Associated with Any Immediate Effect on Stroke Occurrence in Finland.

Authors:  Jussi O T Sipilä; Jori O Ruuskanen; Jussi P Posti; Päivi Rautava; Ville Kytö
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.